Multiple Sclerosis Information
Search
I would appreciate a donation. I spend a lot of time every day in researching for articles and the latest research on MS. When an something is written in medical terminology I translate it into non-medical terms. I can no longer work because of my MS.
This Month
February 2009
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
View Article  Study - Vitamin D helps control genes that trigger MS

Vitamin D helps control genes that trigger MS: study

 

 

Researchers have discovered direct evidence that shows vitamin D may help control the genes that trigger multiple sclerosis.

In a new study, published in the journal PLoS Genetics, researchers say they've found a direct link between vitamin D and a gene variant, known as DRB1*1501, that is susceptible to MS.

 

Prof. George Ebers, with the University of Oxford, said researchers have known for a long time that genes and environment determine MS risk.  "This is the first evidence that the environment, in the form of vitamin D, is directly related to the gene region that gives you the major risk for MS,"

 

The study, funded in part by the MS Society of Canada, found that proteins activated by vitamin D in the body bind to a particular DNA sequence lying next to the DRB1*1501 variant, in effect switching the gene on.   If there isn't enough vitamin D available in the body, the DRB1*1501 gene may not function properly.

 

 

In the U.K., one in 1,000 people are likely to develop MS but the chance increases to one in 300 among those carrying a single copy of the DRB1*1501 gene variant.  The chance increases to one in 100 among those carrying two copies.

 

Around the world, 2.5 million people suffer from MS, which results from the loss of nerve fibres and their protective myelin sheath in the brain and spinal cord, causing neurological damage.

 

Previous studies have shown that people who live in areas receiving less sunshine have an increased risk of developing MS as sunlight produces vitamin D in the body.

 

The lead author of the recent study, Dr. Sreeram Ramagopalan, said  the new research "implies that taking vitamin D supplements during pregnancy and the early years may reduce the risk of a child developing MS in later life,". 

 

Ebers said he'd like to see all women taking vitamin D while pregnant.  "The evidence is strong that vitamin D is very important in early development of the fetus," he said.

 

Levi Barron developed MS around the age of 12.  Now 16, Levi has responded to treatment and is "pretty much ok," says his mother, Karen.   She said they now both regularly take vitamin D.  "It's quite a little vitamin that's turning out to really knock everybody's socks off with where the research is going with it," Levi's mother.  Karen Barron said taking vitamin D was something she didn't think of during her pregnancy.  "I would strongly encourage any pregnant women to talk to their family doctor and find out what dosage of vitamin D they should be taking," she said.

 

View Article  Liquinimod: Phase III Trial of Oral Drug by Teva
- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech AB (OMX NORDIC: ACTI) announced today that patients are being enrolled for the BRAVO Phase III pivotal trial. BRAVO is a global, 24-month, double-blind study designed to evaluate the efficacy, safety and tolerability of the oral compound   more »
View Article  health benefits and risks, involving vitamin D or skin cancer

MEDICAL SCIENCES
Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure


*Department of Radiation Biology,

Institute for Cancer ...   more »

View Article  MS That Runs In Families

MS That Runs In Families Appears More Severe Than Non-familial MS

 

Science Daily —

 

Magnetic resonance images (MRI) of a large group of ...   more »

View Article  Small Study Investigating Combination Therapy

Small Study Investigating Combination Therapy Including Antibiotics For Multiple Sclerosis, UK

 

 

A preliminary study suggests that combining beta interferon with an antibiotic may ...   more »

View Article  Tolerogenic DNA Plasmid Vaccine Decreases Brain Lesions in MS

Tolerogenic DNA Plasmid Vaccine Decreases Brain Lesions in MS Patients:

 

Presented at ECTRIMS

 

PRAGUE, CZECH REPUBLIC

 

Intramuscular injection of the tolerogenic DNA ...   more »

View Article  Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For RRMS

Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis


Jerusalem, Israel and
Lund, Sweden,

Teva Pharmaceutical Industries Ltd. ...   more »

View Article  Can a vitamin alleviate chronic, progressive MS?

Can a vitamin alleviate chronic, progressive multiple sclerosis?

Ongoing nerve-fiber damage, disability prevented in animal study

Researchers have found a possible way to protect people ...   more »

View Article  Using Pedometers to Increase Physical Activity and Improve Health

Using Pedometers to Increase Physical Activity and Improve Health

 

Context

 Without detailed evidence of their effectiveness,pedometers have recently become popular as a tool ...   more »

View Article  Treatment with Natalizumab in Patients with Multiple Sclerosis

Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the  Peripheral Blood.

 

Introduction:

 

Under physiological ...   more »

View Article  Optical coherence tomography and disease subtype in multiple sclerosis.

Optical coherence tomography and disease subtype in multiple sclerosis.

Department of Neurology,

Johns Hopkins University,

School of Medicine,

Baltimore, MD,

USA.

OBJECTIVE:

 

To examine ...   more »

View Article  Rituximab in Adults With Relapsing-Remitting Multiple Sclerosis (RRMS)

Rituximab in Adults With Relapsing-Remitting Multiple Sclerosis:

 

PRAGUE, CZECH REPUBLIC –

 

A single course of rituximab is safe and well tolerated, and compared ...   more »

View Article  Interferon Beta-1b in Combination With Azathioprine for Secondary Progressive Multiple Sclerosis

Interferon Beta-1b in Combination With Azathioprine for Secondary Progressive Multiple Sclerosis

 

PRAGUE, CZECH REPUBLIC –

 

The addition of azathioprine to standard treatment with ...   more »

View Article  Treatment of active secondary progressive multiple sclerosis with treosulfan

Treatment of active secondary progressive multiple sclerosis with treosulfan.

Dept. of Neurology,

University of Wuerzburg,

Wuerzburg, Germany,

 


OBJECTIVE:

 

To study the safety and ...   more »

View Article  New natural history of interferon-beta-treated RRMS

New natural history of interferon-beta-treated relapsing multiple sclerosis.

Department of Neurological and Psychiatric Sciences,

University of Bari,

Bari, Italy.

OBJECTIVE:

 

To investigate the impact ...   more »